Sign in to continue:

Friday, February 13th, 2026

Megachem Limited to Release FY2025 Unaudited Financial Results on 25 February 2026 – Dividend Details Not Announced 1

Megachem Limited: Announcement of FY2025 Financial Results Release

Megachem Limited has notified shareholders of the upcoming release of its unaudited financial results for the full year ended 31 December 2025. According to the company’s official announcement, the results will be published after trading hours on Wednesday, 25 February 2026.

Key Financial Metrics & Analysis

At this time, the company has not yet disclosed any key financial metrics, earnings, revenue, EPS figures, or dividend information for the reporting period. The announcement is solely to inform the market of the future release date of the unaudited results.

Chairman’s Statement

There is no Chairman’s Statement included in the current announcement.

Significant Events and Corporate Actions

No significant events, corporate actions, asset revaluations, exceptional items, or changes in the macroeconomic environment were disclosed in this announcement.

Conclusion & Investor Recommendations

Performance and Outlook: As the financial results have not yet been released, there is no information available to assess Megachem Limited’s recent performance or outlook. Investors are advised to await the publication of the full year unaudited results on 25 February 2026 for a comprehensive evaluation of the company’s financial health and prospects.

  • If you currently hold Megachem Limited shares: Maintain your position and review the forthcoming financial results. Re-assess your investment based on the detailed financial disclosures and management commentary expected in the upcoming report.
  • If you do not currently hold Megachem Limited shares: It is prudent to wait for the release of the full year results before considering any investment decision. The upcoming financials will provide essential insights into the company’s profitability, growth trajectory, and risk factors.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. All recommendations are based solely on the content of the company’s latest announcement. Investors should consult their own financial advisors and conduct further research before making investment decisions.

View MegaChem Historical chart here



China Medical System Holdings Limited Interim Results H1 2025: Turnover Up 10.8%, Profit Rises 3.1%, Declares Interim Dividend of RMB0.1555 Per Share 144

China Medical System Holdings Limited (CMS) Interim Results Analysis: H1 2025 China Medical System Holdings Limited (CMS), a Cayman Islands-incorporated pharmaceutical group, released its unaudited interim results for the six months ended 30 June...

HC Surgical Specialists Limited Reports 11.7% Profit Growth for HY2026 and Declares 0.90 Cents Interim Dividend Payable on 13 March 2026

HC Surgical Specialists Limited: Interim Financial Analysis – HYFY2026 HC Surgical Specialists Limited (HCSS), a Singapore-listed medical services group operating 18 clinics across the island, has released its condensed interim financial statements for the...

GP Industries Reports 62.9% Profit Growth in 1H FY2025, Raises Interim Dividend

GP Industries: Net Profit Growth of 62.9% in 1HFY2025 – Investment Analysis GP Industries: Net Profit Growth of 62.9% in 1HFY2025 – Investment Analysis Business Description Revenue Streams and Customer Base The company’s revenue...